INDUSTRIAL PHYCOLOGY LIMITED

Their core work

Industrial Phycology Limited is a UK-based technology SME specializing in the industrial application of algae for wastewater treatment and biomass value recovery. Their core product is an algae-based tertiary wastewater treatment system designed to clean effluent beyond what conventional biological treatment achieves, while simultaneously harvesting algae biomass that can be converted into valuable byproducts. They followed the classic H2020 SME Instrument pathway — first validating the market opportunity, then securing phase-two funding to develop a full commercial system. Their work sits at the intersection of environmental engineering, bioeconomy, and circular resource management.

What they specialise in

How they've shifted over time

Industrial Phycology's H2020 trajectory is short but coherent: they entered in 2015 with a market feasibility study (IPHYC-H2020, €50k) and immediately scaled to a full R&D and commercialization project (INDALG, €1.47M, running to 2019). The key evolution visible in the project titles is the addition of "value recovery" in INDALG — moving from a single-purpose treatment system to a dual-output model where cleaned water and harvested biomass are both commercial products. No keyword data is available to trace finer shifts in technical focus, so this conclusion rests solely on the project scope descriptions.

Their trajectory points toward a full algae biorefinery model — treating wastewater as a feedstock rather than a problem, with commercial value extracted from both the cleaned effluent and the harvested biomass.

How they like to work

Industrial Phycology has acted exclusively as project coordinator across both H2020 projects, indicating a preference — or capability — to lead rather than join. However, no consortium partners are recorded in the data, which suggests they may have operated as a solo SME under the SME Instrument scheme, which was specifically designed for individual companies rather than consortia. Anyone considering collaboration should expect to engage them as the technology owner and lead partner, not as a service provider within someone else's consortium.

The available data records zero unique consortium partners and zero collaborative countries, consistent with the SME Instrument funding model where a single company leads without a formal multi-partner consortium. Their external network — industry contacts, pilot site partners, customers — is not visible in this dataset.

What sets them apart

Industrial Phycology occupies a specific niche: they are not an academic algae research group, but a private company built around one commercially-focused technology — algae-based tertiary wastewater treatment. The name "Industrial Phycology" itself signals this positioning: applying the science of algae directly to industrial problems. For a consortium builder, they bring a proprietary technology and SME commercial drive, rather than general research capacity.

Highlights from their portfolio

• INDALG
  At €1.47M, this is their flagship project — a full SME Instrument Phase 2 grant covering development, demonstration, and market launch of their algae treatment and value recovery system, running from 2016 to 2019.
• IPHYC-H2020
  A successful SME Instrument Phase 1 feasibility project that validated the EU market opportunity and directly unlocked the larger INDALG Phase 2 funding — a textbook use of the H2020 SME pathway.